



The COVID-19 in 2020 puts forward higher requirements and challenges for the coordinated development of the whole domestic pharmaceutical cold chain. As an important guarantee for pharmaceutical safety, pharmaceutical cold chain logistics brings new challenges and opportunities in application scope, equipment, technology, infrastructure construction, and other aspects under the dual drive of regulations, policies, and the market.
In the future, facing the increasingly mature medical cold chain field in China, Supercooler Cold Chain will fully play its role, continuously improve its technological research and development capabilities, increase innovation and development efforts, and provide a more mature one-stop solution for the industry.